|
DE2034118A1
(en)
|
1970-07-09 |
1972-01-13 |
Seinfeld, Hugo, Brendel, Walter, Prof Dr . 8000 München |
Xenogenic nucleic acids for enhancing antigenicity - of peptides and proteins
|
|
US5374426A
(en)
|
1986-09-03 |
1994-12-20 |
University Of Saskatchewan |
Rotavirus nucleocapsid protein VP6 in vaccine compositions
|
|
US5057540A
(en)
|
1987-05-29 |
1991-10-15 |
Cambridge Biotech Corporation |
Saponin adjuvant
|
|
US4912094B1
(en)
|
1988-06-29 |
1994-02-15 |
Ribi Immunochem Research Inc. |
Modified lipopolysaccharides and process of preparation
|
|
GB8913737D0
(en)
|
1989-06-15 |
1989-08-02 |
Univ Birmingham |
A novel anti-allergy treatment
|
|
US5039813A
(en)
|
1990-06-29 |
1991-08-13 |
Polaroid Corporation |
2-(4-alkenylphenyl)-5-oxazolones and polymers thereof
|
|
EP0468520A3
(en)
|
1990-07-27 |
1992-07-01 |
Mitsui Toatsu Chemicals, Inc. |
Immunostimulatory remedies containing palindromic dna sequences
|
|
AU9052091A
(en)
|
1990-12-20 |
1992-07-22 |
Smithkline Beecham Biologicals (Sa) |
Vaccines based on hepatitis b surface antigen
|
|
GB9101550D0
(en)
|
1991-01-24 |
1991-03-06 |
Mastico Robert A |
Antigen-presenting chimaeric protein
|
|
GB9114003D0
(en)
|
1991-06-28 |
1991-08-14 |
Mastico Robert A |
Chimaeric protein
|
|
GB9213601D0
(en)
|
1992-06-26 |
1992-08-12 |
Mastico Robert A |
Protein based delivery system
|
|
DE69316369D1
(en)
|
1992-07-27 |
1998-02-19 |
Hybridon Inc |
Oligonukleotid alkylphosphonothiate
|
|
FR2695563B1
(fr)
|
1992-09-11 |
1994-12-02 |
Pasteur Institut |
Microparticules portant des antigènes et leur utilisation pour l'induction de réponses humorales ou cellulaires.
|
|
US6727230B1
(en)
|
1994-03-25 |
2004-04-27 |
Coley Pharmaceutical Group, Inc. |
Immune stimulation by phosphorothioate oligonucleotide analogs
|
|
WO1995026204A1
(en)
|
1994-03-25 |
1995-10-05 |
Isis Pharmaceuticals, Inc. |
Immune stimulation by phosphorothioate oligonucleotide analogs
|
|
US6429199B1
(en)
|
1994-07-15 |
2002-08-06 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules for activating dendritic cells
|
|
DE69535036T3
(de)
|
1994-07-15 |
2011-07-07 |
The University of Iowa Research Foundation, IA |
Immunomodulatorische oligonukleotide
|
|
US7935675B1
(en)
|
1994-07-15 |
2011-05-03 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules
|
|
US6239116B1
(en)
|
1994-07-15 |
2001-05-29 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules
|
|
US6207646B1
(en)
|
1994-07-15 |
2001-03-27 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules
|
|
US5935821A
(en)
|
1995-01-17 |
1999-08-10 |
Board Of Trustees Of The University Of Kentucky |
Polynucleotides related to monoclonal antibody 1A7 and use for the treatment of melanoma and small cell carcinoma
|
|
CN1185811A
(zh)
|
1995-03-31 |
1998-06-24 |
H·沃尔夫 |
依赖于逆转录病毒样颗粒的抗原呈递系统
|
|
US5994315A
(en)
|
1995-06-07 |
1999-11-30 |
East Carolina University |
Low adenosine agent, composition, kit and method for treatment of airway disease
|
|
ES2172764T3
(es)
|
1996-01-23 |
2002-10-01 |
Icn Pharmaceuticals |
Modulacion de la expresion de citoquina th1/th2 por ribavirina en linfocitos t activados.
|
|
CZ235798A3
(cs)
|
1996-01-24 |
1999-03-17 |
Aliatros Medical, A. S. |
Prostředek pro léčení rakoviny a způsob jeho výroby
|
|
CA2244946C
(en)
|
1996-01-30 |
2010-04-13 |
The Regents Of The University Of California |
Gene expression vectors which generate an antigen specific immune response and methods of using the same
|
|
GB9621091D0
(en)
|
1996-10-09 |
1996-11-27 |
Fondation Pour Le Perfectionem |
Attenuated microorganisms strains and their uses
|
|
JP4111403B2
(ja)
|
1996-10-11 |
2008-07-02 |
ザ リージェンツ オブ ザ ユニバーシティー オブ カリフォルニア |
免疫刺激ポリヌクレオチド/免疫調節分子複合体
|
|
EP0855184A1
(en)
|
1997-01-23 |
1998-07-29 |
Grayson B. Dr. Lipford |
Pharmaceutical composition comprising a polynucleotide and an antigen especially for vaccination
|
|
GB9702021D0
(en)
|
1997-01-31 |
1997-03-19 |
Imperial College |
Medicaments
|
|
AU738513B2
(en)
|
1997-02-28 |
2001-09-20 |
University Of Iowa Research Foundation, The |
Use of nucleic acids containing unmethylated CpG dinucleotide in the treatment of LPS-associated disorders
|
|
US6406705B1
(en)
|
1997-03-10 |
2002-06-18 |
University Of Iowa Research Foundation |
Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant
|
|
AU7350798A
(en)
|
1997-04-29 |
1998-11-24 |
Universiteit Utrecht |
Corona virus-like particles as tools for vaccination and therapy
|
|
CA2288129A1
(en)
|
1997-05-01 |
1998-11-12 |
Chiron Corporation |
Use of virus-like particles as adjuvants
|
|
EP1003531B1
(en)
|
1997-05-20 |
2007-08-22 |
Ottawa Health Research Institute |
Processes for preparing nucleic acid constructs
|
|
DE69819150T3
(de)
|
1997-06-06 |
2007-12-20 |
Dynavax Technologies Corp., San Diego |
Immunstimulierende oligonucleotide, zusammensetzungen davon, und verfahren zur verwendung davon
|
|
WO1998058951A1
(en)
|
1997-06-23 |
1998-12-30 |
Ludwig Institute For Cancer Research |
Isolated nona- and decapeptides which bind to hla molecules, and the use thereof
|
|
DE19731784A1
(de)
|
1997-07-24 |
1999-02-04 |
Bayer Ag |
Substituierte N-Aryl-N-thioxocarbonyl-sulfonamide
|
|
US6169175B1
(en)
|
1997-08-06 |
2001-01-02 |
Centers For Disease Control And Prevention |
Preparation and use of recombinant influenza A virus M2 construct vaccines
|
|
CA2302805A1
(en)
|
1997-09-05 |
1999-03-11 |
The Regents Of The University Of California |
Use of immunostimulatory oligonucleotides for preventing or reducing antigen-stimulated, granulocyte-mediated inflammation
|
|
US6171591B1
(en)
|
1997-12-08 |
2001-01-09 |
Pentamer Pharmaceuticals, Inc. |
Recombinant nodavirus compositions and methods
|
|
EP1067956B1
(en)
|
1998-04-03 |
2007-03-14 |
University Of Iowa Research Foundation |
Methods and products for stimulating the immune system using immunotherapeutic oligonucleotides and cytokines
|
|
US5990085A
(en)
|
1998-05-04 |
1999-11-23 |
Michigan State University |
Inhibin-HBc fusion protein
|
|
AU760795B2
(en)
|
1998-05-14 |
2003-05-22 |
Coley Pharmaceutical Gmbh |
Methods for regulating hematopoiesis using CpG-oligonucleotides
|
|
ES2284275T3
(es)
|
1998-06-30 |
2007-11-01 |
Om Pharma |
Nuevos pseudodipeptidos acilados, su procedimientos de preparacion y las composiciones farmaceuticas que los incluyen.
|
|
CA2333854A1
(en)
|
1998-07-27 |
2000-02-10 |
University Of Iowa Research Foundation |
Stereoisomers of cpg oligonucleotides and related methods
|
|
US5962636A
(en)
|
1998-08-12 |
1999-10-05 |
Amgen Canada Inc. |
Peptides capable of modulating inflammatory heart disease
|
|
WO2000014217A2
(en)
|
1998-09-03 |
2000-03-16 |
Coley Pharmaceutical Gmbh |
G-motif oligonucleotides and uses thereof
|
|
ATE314095T1
(de)
|
1998-10-21 |
2006-01-15 |
Us Health |
Virusähnliche partikel zur induktion von autoantikörpern
|
|
AU768807B2
(en)
|
1998-11-30 |
2004-01-08 |
Cytos Biotechnology Ag |
Ordered molecular presentation of antigens, method of preparation and use
|
|
MXPA01006491A
(es)
|
1998-12-23 |
2003-06-06 |
Thompson Boyce Plant Res |
Expresion de antigenos de superficie de hepatitis b inmunogenicos en plantas transgenicas.
|
|
EP1141314A2
(en)
|
1998-12-31 |
2001-10-10 |
Chiron Corporation |
Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof
|
|
EP1165773A4
(en)
|
1999-02-02 |
2005-01-05 |
Biocache Pharmaceuticals Inc |
IMPROVED PLATFORM FOR PRESENTING ANTIGENS
|
|
JP2002537403A
(ja)
|
1999-02-25 |
2002-11-05 |
スミスクライン ビーチャム バイオロジカルズ ソシエテ アノニム |
IgEのC−イプシロン−3またはC−イプシロン−4ドメイン由来のエピトープまたはミモトープ、その拮抗薬、及びそれらの治療的使用
|
|
EP2286792A1
(en)
|
1999-02-26 |
2011-02-23 |
Novartis Vaccines and Diagnostics, Inc. |
Microemulsions with an adsorbent surface, comprising a microdroplet emulsion
|
|
WO2000054803A2
(en)
|
1999-03-16 |
2000-09-21 |
Panacea Pharmaceuticals, Llc |
Immunostimulatory nucleic acids and antigens
|
|
US6977245B2
(en)
|
1999-04-12 |
2005-12-20 |
The United States Of America As Represented By The Department Of Health And Human Services |
Oligodeoxynucleotide and its use to induce an immune response
|
|
CA2370697C
(en)
|
1999-04-19 |
2012-03-06 |
Smithkline Beecham Biologicals S.A. |
Adjuvant composition comprising saponin and an immunostimulatory oligonucleotide
|
|
ES2250151T3
(es)
|
1999-06-29 |
2006-04-16 |
Glaxosmithkline Biologicals S.A. |
Uso de cpg como adyuvante de vacuna contra vih.
|
|
EP1204425B1
(en)
|
1999-08-19 |
2009-01-07 |
Dynavax Technologies Corporation |
Methods of modulating an immune response using immunostimulatory sequences and compositions for use therein
|
|
AU6801800A
(en)
|
1999-08-30 |
2001-03-26 |
Ludwig Institute For Cancer Research |
Isolated nona and decapeptides which bind to hla molecules, and the use thereof
|
|
JP2001151698A
(ja)
|
1999-09-10 |
2001-06-05 |
Nichiko Pharmaceutical Co Ltd |
インフルエンザワクチン
|
|
KR100863630B1
(ko)
|
1999-09-25 |
2008-10-15 |
유니버시티 오브 아이오와 리써치 파운데이션 |
면역자극성 핵산
|
|
US6949520B1
(en)
|
1999-09-27 |
2005-09-27 |
Coley Pharmaceutical Group, Inc. |
Methods related to immunostimulatory nucleic acid-induced interferon
|
|
IL148844A0
(en)
|
1999-09-27 |
2002-09-12 |
Coley Pharm Group Inc |
Methods related to immunostimulatory nucleic acid-induced interferon
|
|
ATE454901T1
(de)
|
1999-10-13 |
2010-01-15 |
Novartis Vaccines & Diagnostic |
Verfahren zur erhaltung zellimmuneantworten gegen proteinen
|
|
US7223398B1
(en)
|
1999-11-15 |
2007-05-29 |
Dynavax Technologies Corporation |
Immunomodulatory compositions containing an immunostimulatory sequence linked to antigen and methods of use thereof
|
|
DE60018601T4
(de)
|
1999-11-24 |
2008-05-21 |
Chiron Corp., Emeryville |
HBV/HCV Virus-ähnliche Partikel
|
|
US20010044416A1
(en)
|
2000-01-20 |
2001-11-22 |
Mccluskie Michael J. |
Immunostimulatory nucleic acids for inducing a Th2 immune response
|
|
AT409085B
(de)
|
2000-01-28 |
2002-05-27 |
Cistem Biotechnologies Gmbh |
Pharmazeutische zusammensetzung zur immunmodulation und herstellung von vakzinen
|
|
WO2001056603A1
(en)
|
2000-02-01 |
2001-08-09 |
Tanox, Inc. |
Cd40-binding apc-activating molecules
|
|
US7585847B2
(en)
|
2000-02-03 |
2009-09-08 |
Coley Pharmaceutical Group, Inc. |
Immunostimulatory nucleic acids for the treatment of asthma and allergy
|
|
US6756044B1
(en)
|
2000-02-09 |
2004-06-29 |
Genvec, Inc. |
Antigenic complexes and methods
|
|
EP1261366A4
(en)
|
2000-02-24 |
2003-06-18 |
Univ Leland Stanford Junior |
ADJUVANT TREATMENT BY IN VIVO ACTIVATION OF DENDRITIC CELLS
|
|
CA2407897A1
(en)
|
2000-05-05 |
2001-11-15 |
Cytos Biotechnology Ag |
Molecular antigen arrays and vaccines
|
|
AUPQ912000A0
(en)
|
2000-07-31 |
2000-08-24 |
Crown In The Right Of The Queensland Department Of Health, The |
Improved virus like particles
|
|
AU2002248185A1
(en)
|
2000-12-14 |
2002-07-16 |
Coley Pharmaceutical Group, Inc. |
Inhibition of angiogenesis by nucleic acids
|
|
US7094409B2
(en)
|
2001-01-19 |
2006-08-22 |
Cytos Biotechnology Ag |
Antigen arrays for treatment of allergic eosinophilic diseases
|
|
US7320793B2
(en)
|
2001-01-19 |
2008-01-22 |
Cytos Biotechnology Ag |
Molecular antigen array
|
|
US7128911B2
(en)
|
2001-01-19 |
2006-10-31 |
Cytos Biotechnology Ag |
Antigen arrays for treatment of bone disease
|
|
US20030050268A1
(en)
|
2001-03-29 |
2003-03-13 |
Krieg Arthur M. |
Immunostimulatory nucleic acid for treatment of non-allergic inflammatory diseases
|
|
WO2003040308A2
(en)
|
2001-07-27 |
2003-05-15 |
The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Use of sterically stabilized cationic liposomes to efficiently deliver cpg oligonucleotides in vivo
|
|
AU2002347404A1
(en)
*
|
2001-09-14 |
2003-04-01 |
Cytos Biotechnology Ag |
In vivo activation of antigen presenting cells for enhancement of immune responses induced by virus like particles
|
|
DE60234375D1
(de)
|
2001-09-14 |
2009-12-24 |
Cytos Biotechnology Ag |
VERPACKUNG VON IMMUNSTIMULIERENDEM CpG IN VIRUSÄHNLICHEN PARTIKELN: HERSTELLUNGSVERFAHREN UND VERWENDUNG
|
|
JP4671389B2
(ja)
|
2001-10-05 |
2011-04-13 |
サイトス バイオテクノロジー アーゲー |
アンジオテンシンペプチド−担体複合体およびその使用
|
|
US7115266B2
(en)
|
2001-10-05 |
2006-10-03 |
Cytos Biotechnology Ag |
Angiotensin peptide-carrier conjugates and uses thereof
|
|
EP1455593B1
(en)
|
2001-10-06 |
2013-07-24 |
Merial Limited |
Methods and compositions for promoting growth and innate immunity in young animals
|
|
ATE419007T1
(de)
|
2001-11-07 |
2009-01-15 |
Cytos Biotechnology Ag |
Antigenraster welche il-5, il-13 oder eotaxin präsentieren, zur behandlung von allergischen, eosinophilen erkrankungen
|
|
ES2316628T3
(es)
|
2001-11-07 |
2009-04-16 |
Cytos Biotechnology Ag |
Disposicion ordenada de antigenos que comprende rankl para el tratamiento de enfermedades oseas.
|
|
TW200303759A
(en)
|
2001-11-27 |
2003-09-16 |
Schering Corp |
Methods for treating cancer
|
|
AU2003205623A1
(en)
|
2002-01-18 |
2003-07-30 |
Cytos Biotechnology Ag |
Prion protein carrier-conjugates
|
|
US20030219459A1
(en)
|
2002-01-18 |
2003-11-27 |
Cytos Biotechnology Ag |
Prion protein carrier-conjugates
|
|
CA2488856A1
(en)
*
|
2002-06-20 |
2003-12-31 |
Cytos Biotechnology Ag |
Packaged virus-like particles for use as adjuvants: method of preparation and use
|
|
EP2351770A1
(en)
|
2002-07-17 |
2011-08-03 |
Cytos Biotechnology AG |
Molecular antigen arrays using a virus like particle derived from the ap205 coat protein
|
|
KR20050027168A
(ko)
|
2002-07-19 |
2005-03-17 |
사이토스 바이오테크놀로지 아게 |
그렐린-캐리어 컨쥬게이트
|
|
EP1594469B1
(en)
|
2003-02-17 |
2007-08-29 |
Peter Burkhard |
Peptidic nanoparticles as drug delivery and antigen display systems
|
|
EP1605973B1
(en)
|
2003-03-26 |
2012-09-26 |
Cytos Biotechnology AG |
Packaging of immunostimulatory oligonucleotides into virus-like particles: methods of preparation and uses
|
|
US20060210588A1
(en)
|
2003-03-26 |
2006-09-21 |
Cytos Biotechnology Ag |
Hiv-peptide-carrier-conjugates
|
|
US7537767B2
(en)
|
2003-03-26 |
2009-05-26 |
Cytis Biotechnology Ag |
Melan-A- carrier conjugates
|
|
US20060251623A1
(en)
|
2003-07-10 |
2006-11-09 |
Caytos Biotechnology Ag |
Packaged virus-like particles
|
|
CA2544240A1
(en)
|
2003-07-22 |
2005-02-17 |
Cytos Biotechnology Ag |
Cpg-packaged liposomes
|
|
NZ546475A
(en)
|
2003-10-30 |
2008-08-29 |
Coley Pharm Gmbh |
C-Class oligonucleotide analogs with enhanced immunostimulatory potency
|
|
MXPA06011851A
(es)
|
2004-04-14 |
2006-12-14 |
Genentech Inc |
Composiciones y metodos para moduilar el desarrollo vascular.
|
|
RU2006146605A
(ru)
|
2004-06-02 |
2008-07-20 |
Цитос Биотехнологи Аг (Ch) |
Медицинские применения конъюгатов-носителей tnf-пептидов из организма кроме человека
|
|
DE102004041340A1
(de)
|
2004-08-20 |
2006-02-23 |
Deutsche Gelatine-Fabriken Stoess Ag |
Nanopartikel und Verfahren zu deren Herstellung
|
|
AU2005286475A1
(en)
|
2004-09-21 |
2006-03-30 |
Cytos Biotechnology Ag |
Virus-like particles comprising a fusion protein of the coat protein of AP205 and an antigenic polypeptide
|
|
US7767212B2
(en)
|
2005-03-18 |
2010-08-03 |
Cytos Biotechnology Ag |
CAT allergen conjugates and uses thereof
|
|
ATE515566T1
(de)
|
2005-05-26 |
2011-07-15 |
Cytos Biotechnology Ag |
Skalierbares fermentationsverfahren
|
|
CN101267834B
(zh)
|
2005-09-28 |
2013-06-05 |
赛托斯生物技术公司 |
白介素-1偶联物及其用途
|
|
JP5484732B2
(ja)
|
2005-12-14 |
2014-05-07 |
サイトス バイオテクノロジー アーゲー |
過敏症の治療のための免疫賦活性核酸パッケージ粒子
|
|
DK2032592T3
(da)
|
2006-06-12 |
2013-09-02 |
Cytos Biotechnology Ag |
Fremgangsmåder til pakning af oligonukleotider til virus-lignende partikler af rna-bakteriofager
|
|
JP5396809B2
(ja)
|
2008-10-17 |
2014-01-22 |
ソニー株式会社 |
固体撮像装置、カメラ、および、固体撮像装置の製造方法
|